BCRX

BioCryst Pharmaceuticals Inc.

Price

$10.07

return (12m)

21.62%

p/e

-6.27

p/bv

-5.31

DIVIDEND YIELD

0.00%

BCRX price

BioCryst Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment BCRX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

7.70%

3 months

20.31%

1 year

21.62%

2 years

28.12%

5 years

-29.13%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals BCRX

Valuation

P/E

-6.27

Sector -4.38

Industry -4.38

P/BV

-5.31

Sector 2.02

Industry 2.02

P/Revenue (PSR)

2.56

Sector -4.40

Industry -4.40

EV/EBITDA

27.90

Sector -263.09

Industry -263.09

EV/EBIT

28.04

Sector -702.90

Industry -702.90

P/EBITDA

-7.93

Sector -4.39

Industry -4.39

P/EBIT

-7.88

Sector -4.73

Industry -4.73

P/Total Assets

4.32

Sector 1.49

Industry 1.49

P/Net Current Assets

-4.57

Sector -11.70

Industry -11.70

P/Working Capital

8.74

Sector -3.19

Industry -3.19

EPS

-1.51

Sector -2.14

Industry -2.14

BVPS

-1.79

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

97.77%

Sector 36.74%

Industry 36.74%

EBITDA Margin

46.60%

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

46.36%

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

-33.29%

Sector -38.22%

Industry -38.22%

Net Profit Margins

-40.90%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.39

Sector 0.03

Industry 0.03

Profitability

ROE

84.68%

Sector -65.14%

Industry -65.14%

ROA

-68.96%

Sector -65.53%

Industry -65.53%

ROIC

254.65%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

2.32

Sector 2.90

Industry 2.90

Net Debt / EBITDA

4.19

Sector -6.07

Industry -6.07

Net Debt / EBIT

4.21

Sector -8.26

Industry -8.26

Net Debt / Equity

-0.94

Sector -1.07

Industry -1.07

Gross Debt / Equity

-1.71

Sector -0.05

Industry -0.05

Equity/Assets

-0.81

Sector 0.41

Industry 0.41

Liabilities/Assets

1.81

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

43.02%

Sector -

Industry -

5Y Earnings CAGR

15.89%

Sector -

Industry -

Fundamentals BCRX

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
BCRX BioCryst Pharmaceuticals Inc.	$10.07	20.17%	0.00%	-6.27	-5.31	84.68%	-40.90%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

BCRX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT BioCryst Pharmaceuticals

BioCryst Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (3 people)

United States

35 years

Founded: 1991

1994

Time since IPO - 32 years

246

Employees

BioCryst Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $2.41 billion, with shareholders equity totaling $-454.29 million.

The company employs approximately 246 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, BioCryst Pharmaceuticals Inc. reported $940.62 million in revenue, generating net income of $-384.68 million.

Key financial metrics include a P/E ratio of -6.27, a price-to-book (P/B) ratio of -5.31, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker BCRX.

Market cap

$2.41 billion

Net worth

$-454.29 million

$-454,290,000.00

Assets

$557.85 million

$557,850,000.00

Total Shares Outstanding

254.00 million

254,000,000

Average Daily Trading Volume

$4.75 million

$4,746,888.00

Sector

Health Care

Industry

Biotechnology

BCRX

BCRX revenue and profits

Financial Results BCRX

DRAG THE FRAME TO SEE MORE DATA

BCRX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of BioCryst Pharmaceuticals (BCRX) today?

A cotação de BioCryst Pharmaceuticals (BCRX) hoje está em US$ 10.07, com uma variação de 21.62% em relação ao último ano. A cotação de BioCryst Pharmaceuticals (BCRX) iniciou o ano negociando na casa dos US$ 7.80 e hoje está em US$ 10.07. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de BioCryst Pharmaceuticals (BCRX) e dados de ações do Ibovespa e mercados internacionais.

Quando BioCryst Pharmaceuticals (BCRX) paga dividendos?

BioCryst Pharmaceuticals (BCRX) não distribuiu dividendos no último ano.

Is BioCryst Pharmaceuticals (BCRX) a good investment?

Atualmente, BioCryst Pharmaceuticals (BCRX) está cotada a US$ 10.07, com um P/L de -6.27, representando um desvio de -634% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 21.62 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 21.62%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy BioCryst Pharmaceuticals (BCRX) stock?

Investir em ações de BioCryst Pharmaceuticals (BCRX) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of BioCryst Pharmaceuticals (BCRX) yield today?

A rentabilidade de BioCryst Pharmaceuticals (BCRX) foi de 7.70% no último mês, 21.62% no último ano e -29.13% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de BioCryst Pharmaceuticals (BCRX) hoje, o investimento total seria de US$ 1,007.00, com base na cotação atual de US$ 10.07.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 1,224.71
Em 5 anos: US$ 713.66
Em 10 anos: US$ 1,007.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

BCRX

BioCryst Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment BCRX

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING BCRX WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT BioCryst Pharmaceuticals

BioCryst Pharmaceuticals Inc.

United States

35 years

1994

246

PROFIT X PRICE BCRX

Financial Results BCRX

BCRX cash flow

Asset, Revenue and Profit Growth - BCRX

BCRX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions